Cost-effectiveness análisis ofmicro-dystrophin: a novel gene therapy for duchenne muscular dystrophy

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Antolin Fontes, Beatriz
• dc.date.accessioned 2020-11-17T16:06:10Z
• dc.date.available 2020-11-17T16:06:10Z
• dc.date.issued 2020
• dc.description Màster Universitari en Economia de la Salud i del Medicament. (UPF Barcelona School of Management) Curs 2017-2020ca
• dc.description Mentor: Aníbal García
• dc.format.mimetype application/pdf*
• dc.identifier.uri http://hdl.handle.net/10230/45788
• dc.language.iso engca
• dc.rights This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licenseca
• dc.rights.accessRights info:eu-repo/semantics/openAccessca
• dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/ca
• dc.title Cost-effectiveness análisis ofmicro-dystrophin: a novel gene therapy for duchenne muscular dystrophyca
• dc.type info:eu-repo/semantics/masterThesisca